Armin Rashidi, MD PhD
Fred Hutchinson Cancer Center
I am an Associate Professor of Medicine (Hematology, Oncology, and Transplantation) at Fred Hutch with clinical trial and computational expertise. I have a broad background with a Master of Science in Clinical Investigation combined with computational sciences training, including a PhD in evolutionary models of aging and a KL2 career development award focused on microbiome bioinformatics. I leverage my clinical and computational expertise to make cancer treatment safer by improving supportive care. I characterize microbiota disruptions in patients with cancer, investigate their clinical significance, and test microbiota restorative therapeutics to improve clinical outcomes. Recently, I led the largest clinical trial of FMT in allogeneic stem cell transplant recipients to date. We used findings from this trial to design the proposed randomized placebo-controlled phase 2 trial of third-party FMT to prevent aGVHD after transplantation.